Establishing secure connection…Loading editor…Preparing document…

TDAP Consent Form

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

Tetanus, Diphtheria and Pertussis Vaccine (Tdap) Vaccine Consent Form

Tetanus is an acute, often fatal disease caused by an extremely potent neurotoxin. The toxin causes neuromuscular dysfunction, with rigidity and spasms of skeletal muscles. The muscle spasms usually involve the jaw (lockjaw) and neck, and then become generalized. Tetanus leads to death in up to 2 cases out of 10.

Diphtheria may cause both localized and generalized disease. It causes a thick covering in the back of the throat and can lead to breathing problems, paralysis, heart failure and even death.

Pertussis (Whooping Cough) is a disease of the respiratory tract, most of caused by B-pertussis. It causes severe coughing spells, pneumonia, vomiting, and disturbed sleep.

Tdap vaccine is recommended for adolescents and adults 11-64 years old. The vaccine is administered in the deltoid only. Tdap may be given during pregnancy (with a note of consent from OB-GYN only).

A. PATIENT INFORMATION – Please Print

B. PAYMENT ARRANGEMENTS

C. ACKNOWLEDGEMENT and AUTHORIZATION

YES NO
Are you allergic to preservatives, neomycin, thimerosal, streptomycin or latex?
Do you have a history of Guillain-Barre syndrome or an active neurological disorder?
Have you ever had a serious reaction after receiving any vaccination?
Do you have a fever, diarrhea, or vomiting today?
For Women: Are you pregnant or suspect you are pregnant? If yes, you must consult your physician.

Check with your physician and/or your healthcare provider before receiving this vaccine if you checked “yes” on any of the above questions.

Participants who should not take the vaccine:

  • Anyone who has had a life-threatening allergic reaction after a dose of DTP, DTap, DT or Td should not get Tdap.
  • Anyone who has a severe allergy to any component of any vaccine should not get that vaccine. Tell your provider of any severe allergies.
  • Anyone who had a coma, or long or multiple seizures within 7 days after a dose of DTP or DTaP should not get Tdap, unless a cause other than the vaccine was found.
  • Talk with your provider if the person getting the vaccine has epilepsy or another nervous system problem, had severe swelling or severe pain after a previous dose of DTP, DTaP, DT, Td, or Tdap vaccine, or has had Guillain Barre Syndrome.
  • Anyone who has a moderate or severe illness on the day of the immunization should usually wait until they recover before getting the vaccine. A person with a mild illness or low fever can usually be vaccinated.

Possible side effects from the vaccine:

  • Most people have no side effects from Tdap vaccines. Injections are given by injection into a muscle of the upper arm. This may cause soreness for a day or two, mild fever, headache, tiredness, nausea, vomiting, diarrhea, stomach ache, chills, body aches, sore joints, rash, swollen glands.

The vaccine should not be administered to people with acute febrile illness until their temporary systems have abated. However, minor illnesses with or without fever should not contraindicate the use of Tdap vaccine, particularly among children with mild respiratory tract infection or allergic rhinitis. This vaccine should not be administered to anyone with a history of hypersensitivity to any component of the vaccine including Thimerosal.

  • I authorize Seattle Visiting Nurse Association (SVNA) records to be released and reviewed by an authorized representative of my third party payer or employer as required for payment. I authorize this information to be released and reviewed by any federal, state, or agency only as required by the regulatory or licensing body.
  • I agree to release and hold harmless SVNA and the venue at which the vaccine is being provided, its employees, officers, directors or affiliates from any and all liability that might arise from or is in any way connected with this vaccine.
  • I have been offered a copy of the HIPAA Privacy Notice for SVNA.
  • I have been offered and read a copy of the Vaccine Information Sheet (VIS) which explains the risks and benefits. I have had the chance to ask questions before vaccination.
  • I understand that it is recommended that, if this is a first vaccination, I will remain in the area for 15 minutes for assistance should any immediate reaction occur. I understand that if I experience any side effects, it is my responsibility to consult my physician at my expense.
  • I understand that I am responsible to reimburse SVNA for charges not covered by my employer, or health insurance.
  • I authorize SVNA to give me Tdap vaccination.

To be completed by Nurse - Vaccine Administered

VIS Date: 01/24/2012

Dose: 0.5 ml IM

Enter text✕

What the TDAP Consent Form Is and When It’s Used

The TDAP Consent Form documents a patient or guardian’s informed consent to receive the Tetanus, Diphtheria, and Pertussis (Tdap) vaccine. It summarizes the vaccine given, site and date of administration, lot or batch number, and any specific risks or contraindications discussed with the patient. Medical staff use the form to record clinical screening questions, verify identity and eligibility, and obtain an explicit signature that authorizes vaccination and medical record entry. The form may also capture permission to share immunization data with public health registries when required.

Why a Proper TDAP Consent Form Matters

A clear consent form establishes patient understanding, documents clinical screening and vaccination details, and creates a legal record for the health provider. Accurate consent reduces administrative disputes, supports compliance with HIPAA and public-health reporting, and protects both patients and clinicians by documenting informed decision-making.

Why a Proper TDAP Consent Form Matters

Typical Users and Signing Parties

Primary users include vaccination clinic staff, school health nurses, primary care providers, and public health clinics who need signed patient authorization before administering Tdap.

  • Clinic staff and nurses responsible for screening and vaccine administration.
  • Parents or legal guardians signing for children under state-defined minor consent ages.
  • Public health officials or school health officers who collect immunization documentation.

Secondary signers include parents or legal guardians for minors, authorized representatives for incapacitated adults, and administrators who file immunization records with registries.

Essential Data Fields to Include

Patient Name: Full legal name as on ID
Date of Birth: MM/DD/YYYY format
Address: Street, city, state, ZIP
Insurance Info: Payer name and policy number
Vaccine Details: Manufacturer and lot number
Consent Statement: Signed authorization line

Step-by-Step: Completing a TDAP Consent Form

Follow these steps during the clinical visit to collect valid consent, record vaccine details, and store the record properly.

  • 01
    Verify Identity: Confirm name and DOB against ID or medical record.
  • 02
    Conduct Screening: Ask contraindication and allergy questions before offering vaccine.
  • 03
    Document Vaccine: Enter manufacturer, lot number, site, and date.
  • 04
    Obtain Signature: Have patient/guardian sign and date the consent line.

How to Set Up an Online TDAP Consent Workflow

Configure your digital workflow to collect identity, clinical screening answers, vaccine metadata, and the signer’s consent reliably.

Field Configuration
Patient Identity Require full name, DOB, and address
Screening Checklist Use required yes/no fields for contraindications
Vaccine Metadata Make manufacturer and lot mandatory fields
Signature Capture Enable typed or drawn signature with timestamp

Digital Signing and Submission: Platform Considerations

Choose a platform that supports secure e-signatures, audit trails, and HIPAA-compliant workflows when handling protected health information.

  • File Formats: Accept PDF and DOCX for reliable archiving
  • Authentication: Use email or SMS codes for signer attribution
  • Integrations: Connect to EHR or immunization registries

Typical eSignature Flow for TDAP Consent

A streamlined online signing flow reduces administrative overhead while preserving legal and clinical requirements.

  • Upload Form: Staff uploads the TDAP template to the signing platform
  • Add Fields: Place identity and signature fields where required
  • Send to Signer: Email or present a secure link for the patient to sign
  • Archive: Signed copy and audit trail saved to records

Key Sections a Professional TDAP Consent Form Should Include

A well-structured TDAP form combines clinical screening, vaccine data capture, informed consent language, and administrative fields to support care, compliance, and reporting.

Patient Details

Full legal name, date of birth, contact and insurance details to match the patient to existing medical records and insurance billing systems.

Clinical Screening

Standardized yes/no questions about allergies, prior adverse reactions, current illness, or immunocompromise that affect vaccine eligibility and safety.

Vaccine Record

Fields for vaccine type, manufacturer, lot number, administration site, route, and provider name for clinical traceability and public health reporting.

Informed Consent Text

Clear language describing common side effects, benefits, risks, and the voluntary nature of vaccination with space for questions and clinician notes.

Signature and Attribution

Signed name, printed name, relation to patient if signing for a minor, date, and method of signature (electronic or wet ink) for legal attribution.

Reporting & Privacy

Checkboxes and consents for reporting to immunization registries and a statement about PHI handling in accordance with applicable privacy laws.

Common Mistakes When Preparing or Using the Form

  • Using incomplete patient identifiers leads to mismatched records and billing denials when matching to an EHR or registry.
  • Leaving vaccine lot numbers or manufacturer fields blank complicates recall management and adverse-event investigations.
  • Accepting an unsigned or undated consent creates legal ambiguity about whether informed consent was obtained.
  • Failing to record screening answers or clinician notes may violate clinic protocols and expose providers to patient-safety risk.

Risks and Compliance Consequences of Incorrect Consent Records

Patient Safety: Missed contraindications risk adverse reactions
Regulatory Exposure: Incomplete records may breach public-health reporting rules
HIPAA Violations: Improper PHI handling can trigger investigation
Insurance Denials: Billing may be refused without proper identifiers
Legal Disputes: Unsigned forms weaken defenses in claims
Recall Traceability: Missing lot numbers hinder rapid response

Timelines and Timing Considerations

Timing rules vary by use case — immediate consent is needed at administration, while reporting and school-entry deadlines follow separate schedules.

Consent at Visit:

Obtain signed consent before administering the vaccine

Same-Day Documentation:

Record vaccine details in the medical record on the day given

Registry Reporting:

Report to immunization information systems per state timing rules

School Requirements:

Provide accepted proof of immunization by school enrollment deadlines

Correction Window:

Correct obvious data errors promptly to maintain record integrity

How the TDAP Consent Form Differs From Similar Documents

Compare the TDAP-specific consent against a general vaccine consent to ensure the right fields and legal statements are present.

Criteria TDAP Consent Form General Vaccine Consent
Vaccine Specifics manufacturer & lot optional
Screening Detail tdap-focused questions broader checklist
School Use designed for school entry generic use
Reporting immunization registry fields may be absent

Selecting an eSignature Provider for TDAP Consent Forms

Key vendor differences include starting price, trial availability, bulk-send support, audit trail presence, HIPAA readiness, and envelope or invite limits; signNow is listed first for direct comparison.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Varies by vendor Varies by vendor Varies by vendor Varies by vendor
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No

Frequently Asked Questions About TDAP Consent Forms

Answers to common questions about legal validity, parental consent, recordkeeping, and electronic signatures for TDAP consent in U.S. clinical settings.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users